Cromwell Holdings LLC Reduces Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Cromwell Holdings LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 14.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 474 shares of the company’s stock after selling 82 shares during the quarter. Cromwell Holdings LLC’s holdings in HCA Healthcare were worth $142,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. Integrated Advisors Network LLC raised its holdings in HCA Healthcare by 0.6% in the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock worth $2,086,000 after purchasing an additional 31 shares in the last quarter. BayBridge Capital Group LLC raised its holdings in HCA Healthcare by 1.0% in the third quarter. BayBridge Capital Group LLC now owns 3,485 shares of the company’s stock worth $1,416,000 after purchasing an additional 35 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in shares of HCA Healthcare by 2.4% during the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after acquiring an additional 36 shares in the last quarter. Mediolanum International Funds Ltd increased its holdings in shares of HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after acquiring an additional 36 shares in the last quarter. Finally, Hartford Funds Management Co LLC increased its holdings in shares of HCA Healthcare by 1.6% during the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after acquiring an additional 39 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on HCA. TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Barclays reduced their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, Bank of America reduced their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Up 0.3 %

Shares of NYSE:HCA opened at $321.46 on Friday. The stock has a 50 day moving average of $313.49 and a 200 day moving average of $351.08. The company has a market cap of $79.83 billion, a PE ratio of 14.63, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm posted $5.90 earnings per share. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.90%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 12.02%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.